Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma / Corradini, P; Milani, R; Ciceri, F; Montefusco, V; Peccatori, J; Mariotti, J; Olivieri, Attilio; Soligo, D; Gianni, Am; Perfetti, V; Bregni, M.. - In: BLOOD. - ISSN 0006-4971. - (2002).
Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma.
OLIVIERI, Attilio;
2002-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
